In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a xalkori Drug Master File in Korea (xalkori KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of xalkori. The MFDS reviews the xalkori KDMF as part of the drug registration process and uses the information provided in the xalkori KDMF to evaluate the safety and efficacy of the drug.
After submitting a xalkori KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their xalkori API can apply through the Korea Drug Master File (KDMF).
click here to find a list of xalkori suppliers with KDMF on PharmaCompass.